Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Periderm prevents pathological epithelial adhesions during embryogenesis.

The Journal of clinical investigation | 2014

Appropriate development of stratified, squamous, keratinizing epithelia, such as the epidermis and oral epithelia, generates an outer protective permeability barrier that prevents water loss, entry of toxins, and microbial invasion. During embryogenesis, the immature ectoderm initially consists of a single layer of undifferentiated, cuboidal epithelial cells that stratifies to produce an outer layer of flattened periderm cells of unknown function. Here, we determined that periderm cells form in a distinct pattern early in embryogenesis, exhibit highly polarized expression of adhesion complexes, and are shed from the outer surface of the embryo late in development. Mice carrying loss-of-function mutations in the genes encoding IFN regulatory factor 6 (IRF6), IκB kinase-α (IKKα), and stratifin (SFN) exhibit abnormal epidermal development, and we determined that mutant animals exhibit dysfunctional periderm formation, resulting in abnormal intracellular adhesions. Furthermore, tissue from a fetus with cocoon syndrome, a lethal disorder that results from a nonsense mutation in IKKA, revealed an absence of periderm. Together, these data indicate that periderm plays a transient but fundamental role during embryogenesis by acting as a protective barrier that prevents pathological adhesion between immature, adhesion-competent epithelia. Furthermore, this study suggests that failure of periderm formation underlies a series of devastating birth defects, including popliteal pterygium syndrome, cocoon syndrome, and Bartsocas-Papas syndrome.

Pubmed ID: 25133425 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: Wellcome Trust, United Kingdom
    Id: 097820
  • Agency: NIAMS NIH HHS, United States
    Id: AR44232
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR044232
  • Agency: Wellcome Trust, United Kingdom
    Id: 088566
  • Agency: Medical Research Council, United Kingdom
    Id: G0901539
  • Agency: Biotechnology and Biological Sciences Research Council, United Kingdom
    Id: BB/H012893/1
  • Agency: Wellcome Trust, United Kingdom
    Id: 082868

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Mouse Anti-Mouse SSEA-1 (carbohydrate from F9 teratocarcinoma) Monoclonal Antibody, Unconjugated (antibody)

RRID:AB_528475

This monoclonal targets Mouse Mouse SSEA-1 (carbohydrate from F9 teratocarcinoma)

View all literature mentions